A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma

NCT06192888 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma
MCL

Interventions

DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Lenalidomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]